206 related articles for article (PubMed ID: 2169208)
1. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
Sharma RP; Janicak PG; Javaid JI; Pandey GN; Gierl B; Davis JM
Am J Psychiatry; 1990 Oct; 147(10):1318-21. PubMed ID: 2169208
[TBL] [Abstract][Full Text] [Related]
2. Phenelzine in depressed patients. Effects on urinary MHPG excretion in relation to clinical response.
Beckmann H; Murphy DL
Neuropsychobiology; 1977; 3(1):49-55. PubMed ID: 895998
[TBL] [Abstract][Full Text] [Related]
3. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
Georgotas A; McCue RE; Friedman E; Cooper T
Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
[TBL] [Abstract][Full Text] [Related]
4. MAO inhibition and clinical response in depressed patients treated with phenelzine.
Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
[TBL] [Abstract][Full Text] [Related]
5. [DST urinary MHPG.SO4 excretion and platelet MAO activity in depression].
Zhou DF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):274-8. PubMed ID: 3833511
[No Abstract] [Full Text] [Related]
6. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
Modai I; Beigel Y; Cygielman G
J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010
[TBL] [Abstract][Full Text] [Related]
7. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
Raft D; Davidson J; Wasik J; Mattox A
Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
[TBL] [Abstract][Full Text] [Related]
8. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
[TBL] [Abstract][Full Text] [Related]
9. Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.
Murphy DL; Brand E; Goldman T; Baker M; Wright C; van Kammen D; Gordon E
J Nerv Ment Dis; 1977 Feb; 164(2):129-34. PubMed ID: 836485
[TBL] [Abstract][Full Text] [Related]
10. A clinical study of the selective MAO-A-inhibitor moclobemide (Ro 11-1163): a comparison of 2 different dosages with particular reference to platelet MAO-activity and urinary MHPG-excretion.
Lensch K; Fuchs G; Böning J; Milech U
Int Clin Psychopharmacol; 1987 Apr; 2(2):165-71. PubMed ID: 3298420
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical variables in delusional depression.
Lykouras E; Markianos M; Malliaras D; Stefanis C
Am J Psychiatry; 1988 Feb; 145(2):214-7. PubMed ID: 2449085
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
Davidson J; McLeod MN; White HL
Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
[TBL] [Abstract][Full Text] [Related]
13. Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions.
Rosenbaum AH; Maruta T; Schatzberg AF; Orsulak PJ; Jiang NS; Cole JO; Schildkraut JJ
Am J Psychiatry; 1983 Mar; 140(3):314-8. PubMed ID: 6829802
[TBL] [Abstract][Full Text] [Related]
14. Urinary MHPG and clinical response to amitriptyline in depressed patients.
Spiker DG; Edwards D; Hanin I; Neil JF; Kupfer DJ
Am J Psychiatry; 1980 Oct; 137(10):1183-7. PubMed ID: 7416262
[TBL] [Abstract][Full Text] [Related]
15. Response of psychotic and nonpsychotic depression to phenelzine.
Janicak PG; Pandey GN; Davis JM; Boshes R; Bresnahan D; Sharma R
Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
[TBL] [Abstract][Full Text] [Related]
16. Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level.
Gaertner HJ; Golfinopoulos G; Breyer-Pfaff U
Pharmacopsychiatria; 1982 Sep; 15(5):170-4. PubMed ID: 7178231
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam.
Mooney JJ; Cole JO; Schatzberg AF; Gerson B; Schildkraut JJ
Am J Psychiatry; 1985 Mar; 142(3):366-7. PubMed ID: 2857533
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
[TBL] [Abstract][Full Text] [Related]
19. Do urinary MHPG and plasma drug levels correlate with response to amitriptyline therapy?
Gaertner HJ; Kreuter F; Scharek G; Wiatr G; Breyer-Pfaff U
Psychopharmacology (Berl); 1982; 76(3):236-9. PubMed ID: 6808543
[TBL] [Abstract][Full Text] [Related]
20. Urinary MHPG excretion and treatment with desipramine or amitriptyline: prediction of response, effect of treatment, and methodological hazards.
Veith RC; Bielski RJ; Bloom V; Fawcett JA; Narasimhachari N; Friedel RO
J Clin Psychopharmacol; 1983 Feb; 3(1):18-27. PubMed ID: 6833519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
